Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$3.34 - $5.82
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | $49.40M |
EV | $60.75M |
Shares Outstanding | 8.98M |
Beta | 0.39 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 11.30% |
EPS | -194.80% |
Operating Cash Flow | -27.90% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -8.21% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
ImmuCell Corporation
ICCC
Sector
Healthcare
Industry
Biotechnology
CEO
Brigham, Michael
Employees
72
Website
immucell.comIPO Date
1987-05-05
Headquarters
56 Evergreen Drive, Portland, Maine, 04103, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved